Pharmacist-led intervention to improve blood pressure control in hypertensive patients
Official title: Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients: a Cluster Randomised Clinical Trial
Run by Xijing Hospital · NCT06558877 · Data updated 2026-11-12
This study tests whether a pharmacist-led program that includes education and support can help people with high blood pressure manage their condition better than just standard health advice.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Xijing Hospital Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | June 20, 2025 |
| Main results expected | September 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | July 28, 2025 |
| Trial ID | NCT06558877 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-80 with poorly controlled hypertension who are currently on antihypertensive medication.
✕Probably not a fit
Patients with well-controlled hypertension or those unable to use smartphones and WeChat may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cluster randomized controlled trial aims to evaluate the effectiveness of a pharmacist-led multifaceted intervention on poorly controlled hypertensive patients across eight tertiary hospitals in China. The study will enroll 800 participants, randomly assigning hospitals to either an intervention or control group. The intervention includes health education, home blood pressure telemonitoring, medication consultation, reminders, and individualized medication regimens, while the control group receives standard health education. Outcomes will be assessed at multiple time points to measure changes in blood pressure control, adherence to medication, and cardiovascular disease risk.
Why it matters
Potential benefit: If successful, this intervention could significantly improve blood pressure management and reduce cardiovascular risks for patients with hypertension.
How similar studies have gone: Previous studies have shown that pharmacist-led interventions can improve medication adherence and health outcomes in hypertensive patients, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (subjects must meet all of the following criteria to be included): * 1\) age 18-80 years; * 2\) patients with hypertension (diagnostic criteria: defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg according to the "Guidelines for the prevention and treatment of hypertension in China in 2023", based on the blood pressure measurement of three times on different days), who are currently taking anti-hypertensive medication and are judged by the research physician to have poor blood pressure control; * 3\) able to use smartphones and WeChat proficiently, and can communicate and upload pictures proficiently; * 4\) able to take care of yourself and communicate normally, and willing to cooperate with the research physician to complete the study and follow-up; * 5\) permanent residents of the city where the center is located; * 6\) voluntarily participate and sign the informed consent form Exclusion Criteria(subjects will be excluded if they meet any of the following criteria): * 1\) patients with advanced disease (such as patients undergoing dialysis or liver failure), or with a life expectancy of less than 2 years as determined by the research physician; * 2\) combined with psychiatric disease, cognitive impairment, communication disorder, or inability to cooperate with the researchers; * 3\) combined with cerebrovascular disease, stroke, severe liver and kidney dysfunction, severe heart failure, cancer and history of organ transplantation, etc.; * 4\) patients who are pregnant, breastfeeding, or planning to conceive in the next 2 years.
Where it's running
-
Xijing hospital
Xi'an, Shaanxi, China Recruiting
Study contacts
- Study coordinator: Qianqian Dong, Doctor
- Email: dongqq@fmmu.edu.cn
- Phone: +8613720451039
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.